Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners

As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant¹ in the amount of €3.8 million.

The grant will fund a four-year project entitled BIO-INSPIRE (Training Program on New Bio-inspired Bone Regeneration) that aims to develop a technology platform consisting of bio-mimetic and bio-active materials as well as train the next generation of leading tissue-engineering scientists. A consortium of seven renowned European academic and industrial partners with paralleled expertise will provide the integral and interdisciplinary training program on bone regeneration. Bone Therapeutics’ role in BIO-INSPIRE will be to identify the therapeutic advantages of the combined use of scaffold and cells for orthopedic applications as well as design subsequent clinical trials. Furthermore, the Company has opened a research fellowship (Postdoctoral) position and will provide training to a PhD candidate in collaboration with the University of Brussels (ULB).

* The BIO-INSPIRE consortium comprises: Fujifilm (recombinant-collagen scaffolds, NL), ISTEC (natural bio-mineralisation, IT), Erasmus Medical Center (growth factor technology, NL), Medicyte GmbH (stem cell technology, DE), Fraunhofer Institute (bone cell therapy, DE) and Universita di Bologna (Orthopaedic Therapies, IT).

1 The Marie Curie grant is an award aimed at stimulating researchers’ career development in response to the needs of Europe’s scientific community and is part of the European Commission Seventh Framework Programme for Research and Innovation (FP7).